Literature DB >> 11125169

VP5 and the N terminus of VP2 are not responsible for the different pathotype of serotype I and II infectious bursal disease virus.

Anja Schröder1, Adriaan A W M van Loon2, Danny Goovaerts2, Jens Peter Teifke1, Egbert Mundt1.   

Abstract

Two serotypes have been identified in infectious bursal disease virus (IBDV), a member of the family BIRNAVIRIDAE: A reverse genetics system was used for generation of chimeras in genome segment A of the two serotypes, in which the complete viral VP5 gene and 3' noncoding region (NCR), or parts thereof, were exchanged. The engineered viruses were characterized in vitro and in vivo in comparison to serotype I and II IBDV. Our results show that IBDV chimeras exhibit a different phenotype in cell culture compared to the wild-type viruses. In in vitro-cultivated bursal-derived cells, chimeric viruses infected B lymphocytes, as does serotype I IBDV. Surprisingly, serotype II virus was also able to infect in vitro-cultivated bursal cells, but these were neither B lymphocytes nor macrophages. After infection of susceptible chickens all chimeras replicated in the bursa of Fabricius (BF), and three chimeric viruses caused mild depletion of bursal cells. In contrast, after infection of chickens with a chimeric IBDV containing exchanged VP5 as well as 3'-NCR, no depletion was detectable. The serotype II strain did not replicate in the BF nor did it cause depletion of bursal cells. Thus, the origin of VP5 does not explain the different pathotype of IBDV serotype I and II.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11125169     DOI: 10.1099/0022-1317-82-1-159

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Sequence variability and evolution of the terminal overlapping VP5 gene of the infectious bursal disease virus.

Authors:  Martín Hernández; Pedro Villegas; Diego Hernández; Alejandro Banda; Leticia Maya; Valeria Romero; Gonzalo Tomás; Ruben Pérez
Journal:  Virus Genes       Date:  2010-05-01       Impact factor: 2.332

2.  Exchange of the VP5 of infectious bursal disease virus in a serotype I strain with that of a serotype II strain reduced the viral replication and cytotoxicity.

Authors:  Liting Qin; Xiaole Qi; Honglei Gao; Yulong Gao; Zhigao Bu; Xiaomei Wang
Journal:  J Microbiol       Date:  2009-06-26       Impact factor: 3.422

3.  Different domains of the RNA polymerase of infectious bursal disease virus contribute to virulence.

Authors:  Cyril Le Nouën; Didier Toquin; Hermann Müller; Rüdiger Raue; Katherine M Kean; Patrick Langlois; Martine Cherbonnel; Nicolas Eterradossi
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

4.  Gallid herpesvirus 3 SB-1 strain as a recombinant viral vector for poultry vaccination.

Authors:  Yashar Sadigh; Claire Powers; Simon Spiro; Miriam Pedrera; Andrew Broadbent; Venugopal Nair
Journal:  NPJ Vaccines       Date:  2018-05-28       Impact factor: 7.344

5.  Glycoprotein Production by Bursal Secretory Dendritic Cells in Normal, Vaccinated, and Infectious Bursal Disease Virus (IBDV)-Infected Chickens.

Authors:  Balázs Felföldi; Zsófia Benyeda; Tamás Kovács; Nándor Nagy; Attila Magyar; Imre Oláh
Journal:  Viruses       Date:  2022-07-30       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.